You are here
OptiLIF®
The goals of an anatomy-conserving interbody fusion procedure are to:
- Place a large implant to immediately provide structural support, restore stability and indirectly decompress the diseased segment
- Perform the procedure through the smallest access possible to avoid trauma to the muscle and reduce compression/stretching of the neural structures to minimize the risk of neurological deficits following surgery
- Efficiently complete the procedure to reduce the duration of time the neural structures are compressed/stretched, to mitigate the risk of neurological deficits following surgery
The OptiLIF® procedure employs Spineology’s proprietary OptiMesh® Multiplanar Expandable Interbody Fusion System to perform interbody fusion through an access smaller than any other fusion procedure. The procedure is performed using specialized, expandable instrumentation that conserves bony anatomy and protects neural structures to provide:
- Enhanced recovery
- Exceptional efficiency
- Proven outcomes backed by FDA IDE clinical trial data
Enhanced Recovery
The OptiLIF procedure conserves bony anatomy and protects neural structures, which means patients recover quickly,1 resulting in:
- Short hospital stays1
- High postoperative patient satisfaction scores1
- Rapid return to work1
- Reduced use of narcotics over time1
Exceptional Efficiency
Concerns about patient welfare and healthcare economics demand the use of increasingly efficient procedures. The OptiLIF procedure leads to exceptional efficiency in surgery and throughout the episode of care through the use of specialized instrumentation and techniques:
- Tissue dilation, instead of broad dissection, and use of a facet-sparing approach speeds access to the disc space.
- In situ filling of OptiMesh can provide indirect decompression, or minimize the complexity of it, reducing procedural time.
- The minimal exposure dramatically speeds incision closure.
- Surgeon rounding requirements are minimized due to short hospital stays.¹
Proven Outcomes
Results of the Spineology Clinical Outcomes (SCOUT) study, an FDA IDE clinical trial, demonstrates the efficacy, reproducibility, and safety of the OptiLIF procedure.1




Safety
The safety profile of this device is exceptional. There were no device-related serious adverse events in the SCOUT IDE study.1
The OptiLIF® procedure employs Spineology’s proprietary OptiMesh® Multiplanar Expandable Interbody Fusion System. To learn more about OptiMesh, click here.
1. Data on file.